News: Successful MHRA Audit of MedPharm Guildford

MedPharm, a global Contract Development and Manufacturing Organization that specializes in topical and transdermal drug product development, recently completed a Medicines and Healthcare products Regulatory Agency (MHRA) GMP audit of its Guildford locations. We are happy to announce there were no critical or major findings from the audit.

These evaluations of MedPharm’s systems and compliance with regulatory standards are further confirmation of MedPharm’s commitment to providing the gold standard in topical development and manufacturing services.   

To learn more about MedPharm’s capabilities, view our virtual facility tours or contact our team today.

About MedPharm

MedPharm is a global contract provider of topical and transdermal formulation development services specializing in reducing risk through unique, cost-effective, and industry-leading performance testing models. MedPharm offers innovative dermal/transdermal, respiratory, mucosal membrane, ophthalmic, and ungual product development solutions with locations in the United Kingdom and the United States. For more information, visit MedPharm.com or follow us on LinkedIn.